C12N 2760/16141
Use of virus, viral particle or viral elements as a vector
C12N2760/16141 (Use of virus, viral particle or viral elements as a vector) appears on 101 US grants and 149 published applications in this corpus.
Search patents in C12N- Granted patents
- 101
- Published applications
- 149
- Assignees
- 81
- Inventors
- 204
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 5 | 4 |
| 2004 | 0 | 6 |
| 2005 | 3 | 7 |
| 2006 | 0 | 4 |
| 2007 | 2 | 1 |
| 2008 | 3 | 2 |
| 2009 | 4 | 8 |
| 2010 | 1 | 6 |
| 2011 | 5 | 5 |
| 2012 | 3 | 12 |
| 2013 | 4 | 6 |
| 2014 | 10 | 12 |
| 2015 | 6 | 3 |
| 2016 | 5 | 6 |
| 2017 | 3 | 12 |
| 2018 | 6 | 4 |
| 2019 | 10 | 7 |
| 2020 | 2 | 8 |
| 2021 | 1 | 5 |
| 2022 | 5 | 5 |
| 2023 | 2 | 13 |
| 2024 | 5 | 8 |
| 2025 | 4 | 1 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2760/16143Viral genome or elements thereof as genetic vectorIndexing code94
- C12N 2760/16142Virus or viral particle as vehicleIndexing code3
- C12N 2760/16145Special targeting system for viral vectorsIndexing code3
- C12N 2760/16144Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
Recent patents
- Avian influenza vaccines and methods of making same28 Jul 2026US 12,691,170 B2The United States of America as represented by the Secretary of Agriculture
- Construction and application of recombinant H5N8 subtype avian influenza virus carrying mapple fluorescence reporter gene16 Jun 2026US 12,655,396 B2South China Agricultural University
- Nucleic acid molecules and dual-functional peptides having antiviral activity and delivery activity, compositions and methods thereof12 May 2026US 12,624,368 B2The University of Hong Kong
- Stabilized 9 and 10 segmented influenza viruses as a vaccine platform and methods of making and using same23 Sep 2025US 12,419,946 B2Duke University
- Influenza viruses with mutant PB2 gene segment as live attenuated vaccines9 Sep 2025US 12,410,409 B2Wisconsin Alumni Research Foundation (WARF)
- Genetic complementation compositions and methods16 Apr 2026US 2026/0101880 A1The Regents of the University of California
- Mutated Influenza Virus, Pharmaceutical Composition, and Use5 Mar 2026US 2026/0061044 A1Ningbo Institute of Marine Medicine, Peking University
- Mrna encoding influenza virus-like particle8 Jan 2026US 2026/0007735 A1Sanofi Pasteur Limited
- Attenuated orthomyxovirus-based vector platform6 Feb 2025US 2025/0043282 A1New York University
- Recombinant virus containing degron, preparation method therefor, and application thereof17 Oct 2024US 2024/0342268 A1Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences
Most cited
By later US patents
- Recombinant negative strand RNA virus expression-systems218US 5,166,057 AMount Sinai School of Medicine of the City University of New York · 1992
- Recombinant negative strand RNA virus expression systems and vaccines171US 5,854,037 AMount Sinai School of Medicine of the City University of New York · 1998
- Recombinant negative strand RNA virus expression systems and vaccines118US 5,820,871 AMount Sinai School of Medicine of the City University of New York · 1998
- Helper-free rescue of recombinant negative strand RNA viruses97US 6,544,785 B1Mount Sinai School of Medicine of New York University · 2003
- Recombinant negative strand RNA viruses82US 6,001,634 A1999